Rentschler Biopharma, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has appointed Mark Caswell as vice president, Site Head.   Caswell joined in July 2022 and is managing all operations at the company’s U.S. facilities in Milford, MA, including the completion of the new state-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) adjacent to the existing site. Experience Caswell has more than 25 years of experience in the biopharmaceutica...